C3 Glomerulopathy research hub

Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN

This study looks at a new medicine called iptacopan for rare kidney diseases (C3G and IC-MPGN). It checks how well it works and if it's safe over a long time. This is for people who were already in earlier studies of this medicine.